InChI=1S/C27H40O5/c1- 15(28) 31- 21- 14- 19- 25(4) 10- 7- 9- 24(2,3) 18(25) 8- 11- 26(19,5) 20- 13- 17(29) 16- 12- 22(30) 32- 23(16) 27(20,21) 6/h12,17- 21,23,29H,7- 11,13- 14H2,1- 6H3/t17- ,18- ,19+,20- ,21+,23- ,25- ,26+,27+/m0/s1 |
TUHLUXIESILORF-ZWRXBZFVSA-N |
[H] [C@] 12OC(=O) C=C1[C@@H] (O) C[C@@] 1([H] ) [C@] 3(C) CC[C@@] 4([H] ) C(C) (C) CCC[C@] 4(C) [C@@] 3([H] ) C[C@@H] (OC(C) =O) [C@] 21C |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(4S,5aS,5bR,7aS,11aS,11bR,13R,13aR,13bS)- 4- hydroxy- 5b,8,8,11a,13a- pentamethyl- 2- oxo- 2,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a,13b- octadecahydrochryseno[1,2- b]furan- 13- yl acetate
|
Hyrtios sesterterpene 2
|
ChEBI
|
9236584
|
Reaxys Registry Number
|
Reaxys
|
8778242
|
PubMed citation
|
Europe PMC
|
|